Close Menu

OpenEye

Biognosys, a swiss proteomics company, said this week that the new version of Spectronaut, its software for analyzing hyper reaction monitoring data, now enables customers automatically generate spectral libraries using search results from Thermo Scientific's Proteome Discoverer platform.

Enzymatics has launched version 3.0 of its Archer Analysis Pipeline. It's the latest incarnation of the company's next-generation sequence analysis platform for detecting and characterizing cancer-causing gene fusions and mutations from clinical samples.

GenBank 200.0 is now available from the National Center for Biotechnology Information via ftp.

Genedata has released a new version of Genedata Expressionist for Mass Spectrometry, its software for the analyzing metabolomics data.
Version 8.0 includes new workflows for integrated processing of LC- and GC-MS data.

The National Center for Biotechnology Information has updated its organism BLAST databases to use top-level — chromosome + unplaced and unlocalized scaffolds — RefSeq genomic records instead of scaffold records.

CLC Bio and BioBam Bioinformatics have released an integrated workflow for researchers working with non-model organisms without reference sequences that combines the Blast2GO PRO plugin and CLC Genomics Workbench.

Certara has released version 13 of the Simcyp Simulator, its software for quantitative prediction of drug-drug-interactions and pharmacokinetic-pharmacodynamic outcomes in virtual populations.

OpenEye has released SZMAP v1.2.
This release adds MPI multiprocessing support along with minor bug fixes, and other improvements.

Lab7 Systems has launched a beta version of its next-generation DNA sequence data workflow management software platform. The company is seeking feedback from beta users that will further development of its software which is expected to launch fully later this year.

The University of California, San Francisco, has released Chimera 1.8.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.